This article reviews the evolving therapeutic landscape for lowering LDL-C and cardiovascular risk, with an emphasis on the role of omega-3 fatty acids.
Cardiovascular Clinical Consult
A key opinion leader discusses effective risk prevention measures and challenges to reducing adverse events. He also considers effective educational resources for self-care.
A discussion on which factors to consider when assessing the need for management/reduction of cardiovascular risk.
An expert physician discusses the role of agents that reduce triglyceride levels and the potential on cardiovascular risk.
A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.
Advertisement
Advertisement
Trending on Medical Economics
1
NPs are registering new practices at nearly 6 times the 2019 rate
2
Patients would rather wait for a clinician’s review than get an instant AI answer to medical questions
3
Flu activity climbs on West Coast; Boston physician sentenced in telemedicine fraud; AI chatbot interviews primary care patients — Morning Medical Update
4
Bill from a No Surprises Act author would end arbitration over out-of-network physician pay
5